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Introduction
Resection of extremity osteosarcoma results in loss of
muscles, large bone defects and, sometimes, loss of
entire joints. The options for reconstruction after
resection of a bone tumor about the knee include the
use of a custom total knee prosthesis, an osteoarticular
allograft or an allograft-joint replacement composite,
an arthrodesis with intercalary bone-grafting, or
conversion to a rotationplasty. The choice of
reconstruction is dependent on several factors,
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including the extent of tumor, the remaining bone and
soft tissue, and the patient’s physical demands and
expectations.
Local resection and arthrodesis for tumors about
the knee was first described in 1908 by Lexer.1,2
During the last 15 years, the method has been
abandoned because of the major concern of total loss
of postoperative knee function. With the advance in
tumor prosthesis, limb and joint salvage procedures
using large custom-made prostheses, sometimes
combined with massive allografts,3,4 became a more
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preferable procedure. There is, however, some suspicion
about the longevity of these prostheses.5 On the other
hand, successful resection–arthrodesis provides a
durable, functional and stable limb. This option was
furthermore presented to patients as an alternative
allowing them to take part in an active life with no
restrictions, other than an immobile knee.
There have been several studies to evaluate the
results of resection–arthrodesis in the treatment of a
tumor.6–9 It was quite successful in controlling the
tumor, but an increase in complications, including
infection, nonunion and late fatigue fracture, made
rehabilitation long and difficult. In the present study,
we tried to determine the oncologic, surgical and
functional results, and the complications of allograft
arthrodesis of the knee in the management of high-
grade osteosarcoma.
Methods
Between January 1991 and March 2001, 19 patients
with high-grade osteosarcoma around the knee were
treated by wide resection and reconstruction using
allograft arthrodesis. All underwent neoadjuvant and
adjuvant chemotherapy. The regimens employed
contained high-dose methotrexate, doxorubicin,
cisplatin and ifosfamide, and they generally followed
the protocols employed by the Pediatric Oncology
Group.10 Our indications for arthrodesis were skeletal-
ly immature patients or extensive involvement of
tumor, especially jeopardizing the extensor mechanism.
Furthermore, we discussed extensively with the patient
(and family) preoperatively regarding the various
options for reconstruction and their functional
consequences.
Ten patients were female and 9 were male. The
mean age at the time of surgery was 13.3 years (range,
6–27 years). All patients were evaluated by clinical
examination, plain roentgenography, computed
tomography (CT) and magnetic resonance imaging of
the primary lesion, radionuclide bone scanning, and
plain chest roentgenography or CT alone. They were
staged by the Musculoskeletal Tumor Society staging
system11 following needle or incisional biopsy. There
were 17 patients with Stage II lesions and 2 with
metastatic disease (Stage III) at presentation. The
tumor involved the distal femur in 12 patients and the
proximal tibia in 7 patients. Mean follow-up was 7.3
years (range, 3–13 years).
All patients underwent an attempted wide or
radical resection of the primary tumor. A long midline
approach was made to the distal half of the femur and
proximal tibia, followed by identification and
displacement of the neurovascular bundle. Marking
of the anterior cortex of the femur and tibia before
resection helped to position the distal part of the
reconstructed extremity in the desired amount of
rotation. The lower limb was expected to be placed in
5–10° of external rotation, with the hip in neutral
rotation. Wide resection was then performed and con-
firmed by frozen sections. Fixations were completed
using intramedullary rod, or broad A-O dynamic
compression plates, or a combination. Rotational and
bending stability of the junctions was examined, and
the final position of the allograft was verified on
intraoperative radiographs. Corticocancellous bone
chips (15 autogenous, 4 allogenous) were applied
primarily around the osteotomy site. Local muscle
flaps (e.g. gastrocnemius) with split-thickness skin
grafts were employed as needed to achieve both tension-
free closure and soft-tissue coverage of the allograft.
Patients were given cefazolin and gentamycin from the
day of operation throughout the first postoperative
week. Oral antibiotics were recommended for the
ensuing 2 weeks. Cast immobilization was used for
1–3 months (mean, 2.4 months) depending on the
type of fixation and the clinical evidence of union.
The patient was allowed to have toe-touch weight
bearing as soon as the incision healed, which then
progressed to full weight bearing over the next 4–6
months. Patients were followed up at approximate
intervals of 2–4 months. Serial radiographs of the
limb, radiographs of the chest, and CT scans were
obtained to determine the presence of metastatic
disease.
All allografts were procured in a sterile fashion
and stored at –80°C until used. When the graft was
removed from the freezer and opened in the operating
room, it was cultured for aerobic and anaerobic
organisms and thawed in warm saline solution with
antibiotics. It was cleaned of unneeded soft tissue and
bone marrow.12 The allograft was matched primarily
by size, if possible, so that the diameters of the
intramedullary canals of the allograft and host bone
were within several millimeters of each other at the
level of the planned diaphyseal junction after the
arthrodesis. For patients who had little or no further
skeletal growth, we aimed to leave the limb about 1–
2 cm shorter than the contralateral limb to facilitate
the swing phase of walking. For patients who had
more than 1 year of potential skeletal growth
remaining, we expected to lengthen the limb by 2–4
cm to accommodate future growth of the contralateral
limb. The mean length of the allograft was 19.5 cm
(range, 12–30 cm).
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For radiographic evaluation, union was defined as
evidence of bridging callus or continuity of cortex in
standard anteroposterior and lateral radiographs.13 We
defined a metaphyseal junction as one between the
metaphyseal end of the allograft and the metaphyseal
bone of either the distal part of the femur or the
proximal end of the tibia, depending on the site of the
tumor. A diaphyseal junction was defined as that
between the diaphysis (that is, cortical bone) of the
allograft and the remaining part of the diaphysis of the
proximal part of the femur or the distal end of the tibia.
Functional evaluation was performed with the system of
the Enneking functional evaluation form (Table 1).11
The evaluation form contains 6 factors. Descriptive
terms such as excellent, good, fair, or poor are not
assigned to a specific numeric range; rather, the result
is expressed as the proportion of expected normal
function for the patient. When each of the factors has
been scored, the sum of the individual factor scores is
calculated for a total score. The maximum possible
score is estimated by multiplying the number of factors
by 5. The rating percentage is determined by dividing
the maximum score into the total score.
Results
Regarding oncologic outcomes, 4 patients (21.1%)
died of their disease in a mean of 3 years (range, 1–6
years). Three patients (15.8%) developed pulmonary
metastases after surgery, but remain alive with disease.
Among the remaining 12 patients (63.2%), 2 had 1 or
more pulmonary metastasectomies; currently, all 12
patients are free of disease. Four patients (21.1%) had
local recurrence of their tumor in a mean of 23 months
(range, 9–44 months) postoperatively. Two of these
patients eventually had an amputation. Another 2
patients died of pulmonary metastases.
Regarding the surgical results, the mean time to
union for the metaphyseal junction was 24.7 weeks
(range, 16–30 weeks), and that for the diaphyseal
junction was 47 weeks (range, 24–78 weeks) (Figure
1). Mean operation time and blood loss were 4.6
hours (range, 3.5–8.5 hours) and 2,100 mL (range,
1,600–4,800 mL). Wide margins were attempted in
all cases; the resection margins were considered to be
wide in 18 cases and marginal in 1, by postoperative
pathologic analysis. No intraoperative complications
Table 1. Enneking functional evaluation form
Score Pain Function Emotional acceptance Supports Walking Gait
5 None No restriction Enthused None Unlimited Normal
4 Intermediate
3 Modest Recreational restriction Satisfied Brace Limited Minor cosmetic
2 Intermediate
1 Moderate Partial disability Accepts 1-cane crutch Inside only Major cosmetic, minor handicap
0 Severe Total disability Dislikes 2-cane crutch Unable unaided Major handicap
Figure 1. A 13-year-old girl with distal femur osteosarcoma of the left leg: (A) immediate postoperative X-ray; (B) solid union over the metaphyseal
junction was achieved 16 weeks postoperatively; (C) solid union over the diaphyseal junction was achieved 26 weeks postoperatively.
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were recorded for any of the 19 patients, but 6 (31.6%)
postoperative complications occurred, including 2
(10.5%) infections, 3 (15.8%) allograft fractures, and
1 (5.3%) nonunion. Infection in the 2 cases was super-
ficial and developed immediately after the opera-
tion. After adequate debridement and appropriate anti-
biotics, the wounds healed without sequelae. Three
(15.8%) allograft fractures occurred in a mean of 4.2
years (range, 3–5.6 years) postoperatively. One of the
3 cases had an accident 3 years after surgery, in which
she fell down; she was treated with revision allograft
arthrodesis, including removing the fractured allograft
as well as previous hardware, and reconstruction with
another allograft and bone grafting (Figure 2). Another
patient refused further treatment because of multiple
pulmonary metastases and eventually died of the disease.
In the other patient, the fracture occurred 5.6 years
postoperatively but was left alone until the seventh
postoperative year when the nail was angulated to 90°
and complicated with severe pain. Finally, the previous
allograft and hardware were removed to correct the
angulation and the limb was lengthened with Ilizarov
external fixators (Figure 3). The only patient with
nonunion was treated with a second reconstructive
operation with a new allograft. The final mean
functional result was 65% (range, 26–85%) according
to the Enneking functional evaluation system.
Discussion
Many factors must be considered when choosing the
reconstruction method after resection of a tumor
about the knee, including the type and extent of the
tumor, the amount of tissue that must be removed to
attain the desired margin, the experience of the surgeon
with the different reconstructive procedures, an
understanding of the advantages and disadvantages
of the reconstructive operations, and the needs and
preferences of the patient. An arthrodesis may be the
Figure 2. An 18-year-old girl with proximal tibia osteosarcoma of the right leg: (A) an allograft fracture was noted on X-ray 3 years
postoperatively; (B) an immediate postoperative X-ray shows revision with a new allograft augmented with bone cement.
A B
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best option of reconstruction for some patients because
of their age, weight or desired level of activity, or
because the extent of resection of bone or soft tissue
makes an arthroplasty impossible. An arthrodesis may
also be indicated as a salvage or back-up procedure
after a prosthetic replacement or an osteoarticular
allograft has failed. Furthermore, an immovable knee
in a good alignment and position can be an appropriate
sacrifice to achieve a stable, pain-free implant for the
rest of the patient’s life.
The major concern of allografts lies in its high
complication rate. Benevenia et al,14 in a follow-up of
Makley’s initial series, evaluated 19 patients who had
been managed with an allograft stabilized with an
intramedullary nail. They reported good results, but
non-oncologic complications were found in 8 patients.
Others have found similar results.15,16 In the present
study, the authors arrived at the same conclusion,
with allograft complications occurring in 31.6% of
patients, including 2 (10.5%) patients with infections,
3 (15.8%) with allograft fractures, and 1 (5.3%) with
nonunion. The 2 infections occurred in our early
patients in whom local rotation flaps were not used
routinely. We attributed the infection to the magnitude
of the soft-tissue resection and inadequate soft-tissue
coverage of the graft to fight infection.
Among the complications in this study, allograft
fracture was the one with the highest incidence
(15.8%; 3 patients). Of the 3 patients, 1 was managed
with revision allograft augmented with poly-
methylmethacrylate and intramedullary rod fixation
to achieve solid union and good functional per-
formance. Another patient who was managed with
removal of the allograft and Ilizarov’s apparatus fixation
had refused early intervention until the previous
intramedullary rod had bent 90°. For allograft
arthrodesis, special techniques have been advocated to
reduce the complication of allograft fracture. Avoiding
screws in the allograft is 1 key technique because a
screw hole would create a stress riser point and induce
excessive allograft resorption mediated by osteoclasts
that often leads to allograft fracture. We also recommend
early intervention with bone-grafting and supplemental
fixation in case there is radiographic evidence of
instability, such as increasing radiolucency along the
nail, especially when accompanied with pain or
tenderness at the junction site. Filling the medullary
canal of the allograft with polymethylmethacrylate
cement seems to lower the incidence of fracture, but
larger series should be conducted to confirm this result.
The oncologic outcomes for patients in the current
study are similar to those reported in another series,17
and it does not appear that limb salvage procedures are
Figure 3. A 7-year-old girl with left distal femur osteosarcoma was
treated with resection–arthrodesis and allograft reconstruction.
(A) At the 7-year postoperative follow-up, an X-ray shows that the
nail has angulated to 90°; the patient was in severe pain. (B) The
immediate postoperative X-ray shows that the previous allograft
and hardware have been removed, correcting the angulation and
lengthening with Ilizarov external fixators.
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associated with a worse disease outcome. However,
our local recurrence rate of 21.1% (4 patients) can be
attributed to the initial severity of the disease (2
patients were stage IIIB) and younger age. As we
know, the knee joint is a more superficial joint. In
young children, the soft tissue envelope is far from
sufficient to allow for a wide marginal resection. Our
final functional results showed a persistently high level
of function with an Enneking functional score of 65%.
In selected patients, resection arthrodesis with
massive bone allografts is an effective reconstructive
method for the management of high-grade
osteosarcoma about the knee. However, allograft
complications are a major concern. Among the
complications, allograft fracture has the highest
incidence.
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